Literature DB >> 26978668

Anxiety sensitivity class membership moderates the effects of pre-quit reduction in anxiety sensitivity on quit-day tobacco craving.

Jafar Bakhshaie1, Michael J Zvolensky2, Kirsten J Langdon3, Adam M Leventhal4, Jasper A J Smits5, Nicholas Allan6, Norman B Schmidt6.   

Abstract

BACKGROUND: Although anxiety sensitivity has been primarily conceptualized as a dimensional latent construct, empirical evidence suggests that it also maintains a latent class structure, reflecting low-, moderate-, and high-risk underlying classes. The present study sought to explore whether these anxiety sensitivity classes moderated the relations between the degree of pre-quit reductions in anxiety sensitivity and the severity of nicotine withdrawal symptoms and craving experienced on quit-day.
METHODS: Participants included 195 adult smokers (47% female; Mage=39.4) participating in a larger "anxiety sensitivity reduction-smoking cessation" intervention trial.
RESULTS: Anxiety sensitivity class significantly moderated relations between pre-quit reduction in anxiety sensitivity and quit-day craving. Specifically, smokers within the anxiety sensitivity high-risk class, who also demonstrated lesser pre-quit reductions in anxiety sensitivity, experienced the highest levels of craving on quit-day.
CONCLUSIONS: These findings highlight the importance of 'high-risk' classes of anxiety sensitivity to better understand the experience of craving on quit day.
Copyright © 2016. Published by Elsevier Ltd.

Entities:  

Keywords:  Anxiety sensitivity; Craving; Smoking; Tobacco; Treatment; Withdrawal symptoms

Mesh:

Year:  2016        PMID: 26978668     DOI: 10.1016/j.janxdis.2016.02.009

Source DB:  PubMed          Journal:  J Anxiety Disord        ISSN: 0887-6185


  5 in total

1.  Enhancing panic and smoking reduction treatment with D-Cycloserine: A pilot randomized clinical trial.

Authors:  Jasper A J Smits; Michael J Zvolensky; Michael W Otto; Megan E Piper; Scarlett O Baird; Brooke Y Kauffman; Eunjung Lee-Furman; Noura Alavi; Christina D Dutcher; Santiago Papini; Benjamin Rosenfield; David Rosenfield
Journal:  Drug Alcohol Depend       Date:  2020-01-22       Impact factor: 4.492

Review 2.  Anxiety and Nicotine Dependence: Emerging Role of the Habenulo-Interpeduncular Axis.

Authors:  Susanna Molas; Steven R DeGroot; Rubing Zhao-Shea; Andrew R Tapper
Journal:  Trends Pharmacol Sci       Date:  2016-11-24       Impact factor: 14.819

Review 3.  Interoceptive anxiety-related processes: Importance for understanding COVID-19 and future pandemic mental health and addictive behaviors and their comorbidity.

Authors:  Michael J Zvolensky; Brooke Y Kauffman; Lorra Garey; Andres G Viana; Cameron T Matoska
Journal:  Behav Res Ther       Date:  2022-06-18

4.  An Integrated mHealth App for Smoking Cessation in Black Smokers With Anxiety: Protocol for a Randomized Controlled Trial.

Authors:  Michael S Businelle; Lorra Garey; Matthew W Gallagher; Emily T Hébert; Anka Vujanovic; Adam Alexander; Krista Kezbers; Cameron Matoska; Jillian Robison; Audrey Montgomery; Michael J Zvolensky
Journal:  JMIR Res Protoc       Date:  2022-05-30

5.  Individual differences in emotion dysregulation and trajectory of withdrawal symptoms during a quit attempt among treatment-seeking smokers.

Authors:  Andrew H Rogers; Jafar Bakhshaie; Lorra Garey; Thomas M Piasecki; Matthew W Gallagher; Norman B Schmidt; Michael J Zvolensky
Journal:  Behav Res Ther       Date:  2018-10-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.